Table 1

Predictors of 5 year mortality in the Melbourne VIP cohort

Risk factor 5 Year mortality (%) χ2, df, p value Multivariate OR (95% CL)
AgeAge as continuous variable:
 40–49, n=8231.7
 50–59, n=9782.8
 60–69, n=8636.6
 70–79, n=44517.1
 80–89, n=14533.1
 90+, n=1752.9258.6, 5, 0.0011.09 (1.07, 1.11)
Sex
 Female, n=17605.71.00
 Male, n=15118.711.1, 1, 0.0011.62 (1.14, 2.30)
Country of birth
 Australia/New Zealand, n=18147.91.00
 British Isles, n=3258.30.92 (0.57, 1.49)
 Greece/Cyprus/Malta, n=2745.10.85 (0.45, 1.58)
 Italy, n=3388.01.03 (0.63, 1.68)
 Other, n=5193.714.1, 4, 0.0070.55 (0.32, 0.92)
Pack years smoking
 None, n=15705.51.00
 ⩽10, n=5395.00.95 (0.57, 1.58)
 11–30, n=5628.51.85 (1.21, 2.85)
 ⩾30, n=58811.726.5, 1, 0.0012.06 (1.38, 3.08)
Duration of high blood pressure
 None, n=23685.71.00
 ⩽5 years, n=3018.60.89 (0.55, 1.48)
 6–10 years, n=1987.60.73 (0.38, 1.48)
 >0 years, n=39414.033.6, 1, 0.0011.51 (1.01, 2.25)
Arthritis
 No, n=25215.4
 Yes, n=74012.848.9, 1, 0.0011.42 (1.02, 1.97)
Best corrected visual acuity
 ⩾6/12, n=32256.6
 <6/12, n=4337.260.6, 1, 0.0012.34 (1.03, 5.32)
Cortical cataract (excluding surgery)
 No, n=28155.5
 Yes, n=36317.471.4, 1, 0.0011.42 (0.98, 2.06)
Nuclear cataract (excluding previous surgery)
 No, n=28885.7
 Yes, n=28918.366.2, 1, 0.0010.81 (0.53, 1.26)
Previous cataract surgery
 No, n=31236.5
 Yes, n=10923.947.8, 1, 0.0011.52 (0.73, 3.15)
Age related maculopathy
 No, n=27085.8
 Yes, n=50113.841.6, 1, 0.0011.36 (0.96, 1.94)
Glaucoma
 No, n=31446.8
 Yes, n=12014.29.5, 1, 0.0021.15 (0.63, 2.11)
Uncorrected refractive error
 No, n=25026.2
 Yes, n=7669.710.6, 1, 0.0011.34 (0.78, 2.31)
Diabetes
 No, n=30926.7
 Yes, n=16913.09.7, 1, 0.0021.34 (0.78, 2.31)
Gout
 No, n=30226.7
 Yes, n=23912.110.2, 1, 0.0010.90 (0.55, 1.47)
Cardiovascular disease
 No, n=29036.0
 Yes, n=34524.1447.1, 1, 0.0011.08 (0.72, 1.61)